
Sign up to save your podcasts
Or
In this episode, we are joined by Dr. Jill Lykon, Clinical Pharmacist Specialist in Hematology at the University of Miami, to discuss the use of IDH inhibitors in relapsed/refractory AML. How do we choose between IDH inhibitors? Is "Olu" the new standard IDH inhibitor in R/R AML, or just the name of a drunk snowman? What about ivosidenib?
4.5
2828 ratings
In this episode, we are joined by Dr. Jill Lykon, Clinical Pharmacist Specialist in Hematology at the University of Miami, to discuss the use of IDH inhibitors in relapsed/refractory AML. How do we choose between IDH inhibitors? Is "Olu" the new standard IDH inhibitor in R/R AML, or just the name of a drunk snowman? What about ivosidenib?
26 Listeners
496 Listeners
185 Listeners
3 Listeners
7,967 Listeners
755 Listeners
12 Listeners
51 Listeners
56 Listeners
134 Listeners
1 Listeners
169 Listeners
48 Listeners
39 Listeners
3 Listeners